These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6256890)
21. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study. Huang JH; Hsu RB Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532 [TBL] [Abstract][Full Text] [Related]
22. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone. Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335 [TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of vancomycin. Cunha BA; Ristuccia AM Clin Pharm; 1983; 2(5):417-24. PubMed ID: 6354567 [TBL] [Abstract][Full Text] [Related]
24. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). Itani KM; Weigelt J; Li JZ; Duttagupta S Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514 [TBL] [Abstract][Full Text] [Related]
25. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Naimi TS; Anderson D; O'Boyle C; Boxrud DJ; Johnson SK; Tenover FC; Lynfield R Clin Infect Dis; 2003 Jun; 36(12):1609-12. PubMed ID: 12802763 [TBL] [Abstract][Full Text] [Related]
26. Staphylococcus aureus with reduced susceptibility to vancomycin in a dialysis graft. Perla RJ; Knutson EL; Fontana JL Clin Infect Dis; 2005 Aug; 41(4):566-7. PubMed ID: 16028171 [No Abstract] [Full Text] [Related]
27. The role of vancomycin in the treatment paradigm. Stevens DL Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121 [TBL] [Abstract][Full Text] [Related]
28. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222 [TBL] [Abstract][Full Text] [Related]
29. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm? Aranha Camargo LF Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006 [TBL] [Abstract][Full Text] [Related]
30. Key considerations in the treatment of complicated staphylococcal infections. Jones RN Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084 [TBL] [Abstract][Full Text] [Related]
31. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227 [TBL] [Abstract][Full Text] [Related]
33. Staph with lower vancomycin resistance in US. OR Manager; 1997 Oct; 13(10):7. PubMed ID: 10174189 [No Abstract] [Full Text] [Related]
34. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin. Burnie J; Matthews R; Jiman-Fatami A; Gottardello P; Hodgetts S; D'arcy S Clin Infect Dis; 2000 Sep; 31(3):684-9. PubMed ID: 11017816 [TBL] [Abstract][Full Text] [Related]
35. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Adra M; Lawrence KR Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775 [TBL] [Abstract][Full Text] [Related]
39. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency. Pai MP; Mercier RC; Allen SE Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618 [TBL] [Abstract][Full Text] [Related]